mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
0.9 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
0.9 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.0021 |
1 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.0019 |
1 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
-0.002 |
1 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.0017 |
1 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
0.0018 |
1 |